Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin M Spithoven

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Urology and Nephrology|May 9, 2026
Exploring novel skin biomarkers related to pruritus in dialysis patientsThomas S van Lieshout, Shannah Bennett, Jop Vreeken, et al.
Kidney International|May 16, 2014
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney diseaseEdwin M Spithoven, Anneke Kramer, Esther Meijer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 8, 2025
Epidemiology and Clinical Impact of Confirmed Respiratory Viral Infections in Solid Organ Transplant RecipientsManon L M Prins, Ernst D van Dokkum, Aiko P J de Vries, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2025
A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Influenza Among Immunocompromised Adults With a Solid Organ TransplantManon L M Prins, Ernst D van Dokkum, Aiko P J de Vries, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 18, 2013
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney diseaseEsther Meijer, Joost P H Drenth, Hedwig d'Agnolo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA RegistryEdwin M Spithoven, Anneke Kramer, Esther Meijer, et al.
Drug Safety|December 21, 2016
Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 StudyMarten A Lantinga, Hedwig M A D'Agnolo, Niek F Casteleijn, et al.
American Journal of Nephrology|September 8, 2017
The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney DiseaseHedwig M A D'Agnolo, Niek F Casteleijn, Tom J G Gevers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 4, 2015
Estimation of total kidney volume in autosomal dominant polycystic kidney diseaseEdwin M Spithoven, Maatje D A van Gastel, A Lianne Messchendorp, et al.
JAMA|November 14, 2018
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical TrialEsther Meijer, Folkert W Visser, Rene M M van Aerts, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Urology and Nephrology|May 9, 2026
Exploring novel skin biomarkers related to pruritus in dialysis patientsThomas S van Lieshout, Shannah Bennett, Jop Vreeken, et al.
Kidney International|May 16, 2014
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney diseaseEdwin M Spithoven, Anneke Kramer, Esther Meijer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 8, 2025
Epidemiology and Clinical Impact of Confirmed Respiratory Viral Infections in Solid Organ Transplant RecipientsManon L M Prins, Ernst D van Dokkum, Aiko P J de Vries, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2025
A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Influenza Among Immunocompromised Adults With a Solid Organ TransplantManon L M Prins, Ernst D van Dokkum, Aiko P J de Vries, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 18, 2013
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney diseaseEsther Meijer, Joost P H Drenth, Hedwig d'Agnolo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA RegistryEdwin M Spithoven, Anneke Kramer, Esther Meijer, et al.
Drug Safety|December 21, 2016
Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 StudyMarten A Lantinga, Hedwig M A D'Agnolo, Niek F Casteleijn, et al.
American Journal of Nephrology|September 8, 2017
The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney DiseaseHedwig M A D'Agnolo, Niek F Casteleijn, Tom J G Gevers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 4, 2015
Estimation of total kidney volume in autosomal dominant polycystic kidney diseaseEdwin M Spithoven, Maatje D A van Gastel, A Lianne Messchendorp, et al.
JAMA|November 14, 2018
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical TrialEsther Meijer, Folkert W Visser, Rene M M van Aerts, et al.
Pageof 3